Results 61 to 70 of about 10,251 (261)
Рациональная фармакотерапия в кардиологии, 2020 Heart failure (HF) is a growing public health problem with an estimated prevalence of 38 million patients worldwide. Congestion and formation of edema – are typical symptoms of heart failure. Diuretics are the mainstay of therapy in heart failure and are
N. M. Gafurova +2 more
doaj +1 more source
Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure [PDF]
, 2009 The aim of this study was to investigate whether torasemide modifies collagen cross-linking in the failing human heart. We analyzed the degree of cross-linking and the expression of the enzyme lysyl oxidase, which regulates cross-linking, in the ...
Beaumont, J. (Javier) +5 more
core
The EuroHeart Failure Survey programme—a survey on the quality of care among patients with heart failure in Europe Part 2: treatment [PDF]
, 2003 National surveys suggest that treatment of heart failure in daily practice differs from guidelines and is characterized by underuse of recommended medications.
Aguilar, JC +17 more
core +2 more sources
Potential drug-drug interactions and adverse drug reactions in patients with liver cirrhosis [PDF]
, 2018 Background and aims: Patients with liver cirrhosis may be at risk for potential drug-drug interactions (pDDIs) and/or adverse drug reactions (ADRs) due to the severity of their disease and comorbidities associated with polypharmacy. Methods: We performed
Born, Christa +4 more
core
European Journal of Heart Failure, Volume 27, Issue 12, Page 2763-2772, December 2025.The ADHF‐ED trial. ADHF, acutely decompensated heart failure; CHF, chronic heart failure; ED, emergency department; EF, ejection fraction; MRA, mineralocorticoid receptor antagonist; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide. Created with the support of AI (ChatGPT).
Michael Kunz +9 more
wiley +1 more source
European Journal of Heart Failure, Volume 27, Issue 12, Page 3134-3141, December 2025.Effects of empagliflozin on sodium and fluid regulation in chronic heart failure (CHF). EF, ejection fraction; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide; NYHA, New York Heart Association. Aims Sodium–glucose co‐transporter 2 inhibitors have become a cornerstone in managing chronic heart failure (CHF).
Venera Bytyqi +11 more
wiley +1 more source
Cardiology Plus, 2022 . Background:. Left ventricular noncompaction (LVNC) is a rare type of cardiomyopathy. The core clinical feature is heart failure that responds poorly to treatments. Case presentation:.
Ya-Wei Yang +3 more
doaj +1 more source
Spectrum of digoxin-induced ocular toxicity: a case report and literature review [PDF]
, 2015 BACKGROUND: Digoxin intoxication results in predominantly digestive, cardiac and neurological symptoms. This case is outstanding in that the intoxication occurred in a nonagenarian and induced severe, extensively documented visual symptoms as well as ...
Delphine Renard +4 more
core +1 more source
Redo mitral valve repair under repeat cardiopulmonary bypass in a dog
Veterinary Surgery, Volume 54, Issue 8, Page 1625-1634, November 2025.Abstract Objective To report the lifelong outcome of a redo mitral valve repair performed under repeat cardiopulmonary bypass (CPB) in a dog. Study design Case report. Animal An 11‐year‐old, 4.0‐kg neutered male Chihuahua, previously treated with surgical mitral valve repair for myxomatous mitral valve disease at the age of eight, presented with ...
Kippei Mihara, Yuya Suzuki, Kentaro Ito
wiley +1 more source
Priprava uzoraka i određivanje diuretika u tjelesnim tekućinama čovjeka pomoću RPHPLC [PDF]
, 2006 This article described reverse phase high-performance liquid chromatography (RPHPLC) methods for determination of diuretics in different human body fluids (whole blood, plasma, serum or urine).
DRAGICA ZENDELOVSKA, TRAJČE STAFILOV
core +1 more source